The dose of febuxostat required to achieve the target level of uric acid in patients with normal and impaired renal function
Febuxostat (FS) is the drug of choice in impaired renal function, but the dosage regimen and the actual efficacy of the maximum allowable doses required to achieve the target uric acid (UA) level in patients with impaired renal function have not been adequately studied.Objective: to compare the dosa...
Saved in:
Main Authors: | M. S. Eliseev, M. N. Chikina, O. V. Zhelyabina, Ya. I. Kuzmina |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2025-04-01
|
Series: | Современная ревматология |
Subjects: | |
Online Access: | https://mrj.ima-press.net/mrj/article/view/1745 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Experience with febuxostat in a patient with severe disabling gout
by: M. S. Eliseev, et al.
Published: (2017-09-01) -
Battle of the strategies: diet versus drug therapy for gout
by: O. V. Zhelyabina, et al.
Published: (2024-06-01) -
Febuxostat in the therapy of gout: from theory to practice
by: E. V. Ilyinykh, et al.
Published: (2018-01-01) -
The place of febuxostat in the treatment of gout
by: A. M. Novikova, et al.
Published: (2020-09-01) -
UPDATED EULAR GUIDELINES FOR THE MANAGEMENT OF GOUT. COMMENTS ON CERTAIN ITEMS
by: M. S. Eliseev
Published: (2018-01-01)